Systems and solutions for medical applications

SmartXide Touch V²LR

Do you already have this product?
Name* :
Family Name* :
Country* :
E-mail* :
Message* :
Type the code from the image

I have read and approved your Privacy Policy (View)
accept not accept
I agree to receive, from time to time, information on DEKA products, services and events.
accept not accept
Banner Smartxide Touch_V2LR_ENG.jpg
Specifically designed for MonaLisa Touch® and Dermatological applications
MonaLisa Touch®
Surgical V²LR
CO₂ - 10600nm


  Where DEKA makes the difference

MonaLisa Touch® is the best-known and most widespread laser procedure designed to treat vulvovaginal conditions. Issues related to gynaecological health are commonly seen in millions of postmenopausal women, breast cancer survivors and hysterectomized women. MonaLisa Touch® provides a unique solution for all women experiencing post‐menopausal symptoms, without any of the adverse side effects caused by drug-based therapies.

MonaLisa Touch® for the Treatment of:
• Genitourinary Syndrome of Menopause
• Vaginal Laxity
• Stress Urinary Incontinence
• Vulvar Lichen Sclerosus
• Vestibulodynia
• Postpartum Perineal Trauma

The graphs show the improvement (%) for the main symptoms of vaginal atrophy (A) and urinary incontinence (B) after 3 MonaLisa Touch® sessions. The study was carried out at the Department of Gynaecology of the San Raffaele Hospital on patients with symptoms of uro-genital atrophy. [Courtesy of S. Salvatore, M.D. - IRCCS San Raffaele Hospital. Milan, Italy]

2009 DEKA was the first company to apply DOT Therapy to vulvovaginal treatments.
2012 In conjunction with Italian centres of excellence, DEKA presented amazing clinical and histological results achieved with the revolutionary MonaLisa Touch® treatment.
PSD®Technology The exclusive Pulse Shape Design technology assures maximum pulse shape flexibility: S-Pulse, D-Pulse, H-Pulse, U-Pulse and CW mode make SmartXide Touch the most effective and versatile laser system. 
D-Pulse The exclusive pulse shape specifically developed for treating vaginal mucosa.
Peer-reviewed studies Clinical assessments of MonaLisa Touch® have been published worldwide in the peer-reviewed literature. In just two and a half years, over 20 international publications have confirmed the great efficacy and safety of this outstanding procedure. 
HiScan V2LR DEKA's exclusive scanning system, specifically designed for V2LR. Different probes are available for specific treatments and conditions.
Multimedia features An integrated photo and video tutorial.

MonaLisa Touch® is certainly the procedure that has the best evidence in medical literature, showing how safe and how good it is. Other lasers still have to produce that evidence and each single laser is completely different from the other, so we cannot actually say that all CO2 lasers produce the same effects with the same safety.”

Stefano Salvatore, M.D.
Head of the Urogynaecology department,
San Raffaele Hospital and Vita Salute, Milan - Italy

“I feel that the MonaLisa Touch® procedure is a game changing technology. It is truly remarkable that such a simple minimally invasive office procedure can be so effective in treating a variety of skin conditions of the vagina and vulva. The success we have seen with this therapy has far exceeded our expectations, with almost all women noting significant improvement or even a complete cure of their condition.”

Mickey Karram, MD
Director of Fellowship Program on Female Pelvic Medicine & Reconstructive Surgery,
The Christ Hospital, Cincinnati - OH (USA)

“I found that MonaLisa Touch® has a beneficial effect on the vaginal microenvironment in women with symptoms of GSM. This laser therapy restores the vaginal equilibrium to a healthier status, as would normally be expected if estrogen levels were sufficient. The more acidic pH of vaginal fluid, achieved after SmartXide Touch therapy, could protect postmenopausal women from vaginal infections, inflammation and possibly from UTIs.”

Stavros Athanasiou, MD, MRCOG
Associate Professor of Urogynaecology
Urogynaecology Unit, 1st Dept. of Obstetrics and Gynaecology, “Alexandra” Hospital
National and Kapodistrian University of Athens, Athens - Greece

“My studies demonstrated that the uniquely delivered DEKA CO2 laser is capable of treating lichen sclerosus effectively. MonaLisa Touch® procedure represents a significant divergence from steroid- and corticosteroid-bulwark dependence and their expected serious side effects.”

Michael S. Baggish, MD, FACS, FACOG
St. Helena Hospital, St. Helena - CA (USA)
Dept. of Obstetrics and Gynecology, University of California, San Francisco - CA (USA)